AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio |
| August 13, 2019 | August 2019 Bond Updates |
|
RESEARCH TRIANGLE PARK, N.C., Aug. 13, 2019 /PRNewswire/ -- AskBio, the world's foremost clinical stage and gene therapy platform company, has acquired Synpromics, the leader in gene control synthetic promoter technology, bioinformatics and intelligent data-driven design that enables more... |
| View more at: https://www.prnewswire.com:443/news-releases/askbio-acquires-synpromics-ltd-and-expands-its-gene-therapy-technology-portfolio-300900332.html |